Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.

Gastroenterology - 1 Mar 2011

Woo Hyun Goo, Wang Xin Wei, Budhu Anuradha, Kim Yun Hee, Kwon So Mee, Tang Zhao-You, Sun Zongtang, Harris Curtis C, Thorgeirsson Snorri S

Abstract excerpt

BACKGROUND & AIMS: Mutations in TP53, a tumor suppressor gene, are associated with prognosis of many cancers. However, the prognostic values of TP53 mutation sites are not known for patients with hepatocellular carcinoma (HCC) because of heterogeneity in their geographic and etiologic backgrounds. METHODS: TP53 mutations were investigated in a total of 409 HCC patients, including Chinese (n = 336) and white (n =...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Neoplastic Stem Cells

Share to Proportional Hazards Models

Share to Reproducibility of Results

Share to Risk Assessment

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 21094160
DOI: 10.1053/j.gastro.2010.11.034
PMCID: PMC3057345

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.PMID 21094160Read ↗

Identification of Novel Characteristics in TP53-Mutant Hepatocellular Carcinoma Using BioinformaticsSemantic proximity Read ↗

Cancer Stem Cells Remodel the Tumor Microenvironment and Influence Immunotherapy Response in Hepatocellular CarcinomaSemantic proximity Read ↗

P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAsSemantic proximity Read ↗

Correlation of Hepatocellular Carcinoma Stemness Indices and Clinical Characteristics and PrognosisSemantic proximity Read ↗

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of potential pseudogenes for predicting the prognosis of hepatocellular carcinomaSemantic proximity Read ↗

TP53 rs28934571 polymorphism increases the prognostic risk in hepatocellular carcinoma.Semantic proximity Read ↗

TP53 R249S mutation detected in circulating tumour DNA is associated with Prognosis of hepatocellular carcinoma patients with or without hepatectomy.Semantic proximity Read ↗

TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk.Semantic proximity Read ↗

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosisSemantic proximity Read ↗

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.Semantic proximity Read ↗

Decreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.